Type 2 diabetes mellitus (T2DM) has become prevalent pandemic disease in view of the modern life style. Both diabetic population and health expenses grow rapidly according to American Diabetes Association. Detecting the potential onset of T2DM is an essential focal point in the research of diabetes mellitus. The intravenous glucose tolerance test (IVGTT) is an effective protocol to determine the insulin sensitivity, glucose effectiveness, and pancreatic b-cell functionality, through the analysis and parameter estimation of a proper differential equation model. Delay differential equations have been used to study the complex physiological phenomena including the glucose and insulin regulations. In this paper, we propose a novel approach to model the time delay in IVGTT modeling. This novel approach uses two parameters to simulate not only both discrete time delay and distributed time delay in the past interval, but also the time delay distributed in a past sub-interval. Normally, larger time delay, either a discrete or a distributed delay, will destabilize the system. However, we find that time delay over a sub-interval might not. We present analytically some basic model properties, which are desirable biologically and mathematically. We show that this relatively simple model provides good fit to fluctuating patient data sets and reveals some intriguing dynamics. Moreover, our numerical simulation results indicate that our model may remove the defect in well known Minimal Model, which often overestimates the glucose effectiveness index. Published by AIP Publishing. https://doi.org/10.1063/1.5008384
Delay differential equations (DDEs) have been frequently used to study complex dynamics observed in nature. More recently, they are used to understand intriguing physiological phenomena such as those expressed by glucose and insulin interaction. We propose a simple set of delay differential equations to model an intravenous glucose tolerance test. This model uses two parameters to simulate not only both discrete time delay and distributed time delay in the past interval, but also the time delay distributed in a past sub-interval. We show that this relatively simple model provides good fit to fluctuating patient data sets and reveals some intriguing dynamics. Most importantly, our model may remove the defect in the well known Minimal Model (MM) which often overestimates the glucose effectiveness (GE) index.
I. INTRODUCTION
Diabetes Mellitus continues to be a leading public health concern, contributing to an overwhelming number of debilitating health ailments, pre-mature death, and billions of dollars ($245 billion in the US in 2012) in medical care costs.
Approximately 29.1 million or 12.3% of American adults age 20 or older have diabetes. 1 Worldwide, there are an estimated 422 million individuals with diabetes mellitus. Additionally, 79 million individuals have prediabetes, a condition that progresses to Type 2 diabetes mellitus (T2DM) at higher than normal rate. The pathogenesis of type 2 diabetes is complex and is mainly related to a progressive increase in insulin resistance (IR) and decline in insulin secretion, while other factors including changes in incretin hormones and renal handling of glucose excretion also play a role. 2 Defects in insulin resistance and insulin secretion are seen early in the course of disease, in fact in the prediabetes phase. 3 Understanding the mechanisms of insulin resistance and defective insulin secretion could provide an opportunity to develop strategies to prevent and treat diabetes.
Insulin is secreted from pancreas in a pulsatile manner under basal conditions with a frequency of 5 to 15 min. Such regular oscillatory secretion is impaired in type 2 diabetes mellitus (T2DM). 4 Defects in pulsatile insulin secretion have been demonstrated in early T2DM and in the relatives of subjects with T2DM. 5 Insulin response to a glucose load sometimes occurs in two phases-a rapid first phase with dramatic increase in insulin levels, followed by a smaller but prolonged second phase that can form a second peak in insulin levels. Loss of first phase insulin secretion occurs early in a)
Author to whom correspondence should be addressed: jiaxu.li@louisville. edu the course of prediabetes and T2DM. 3 Legacy work by O'Rahilly et al. 6 showed that a significant peak at 13 to 14 min exists in the insulin dynamics of the non-diabetic people, but it is lacking in type 2 diabetic individuals and the relatives of T2DM. Thus, it is concluded that the lack of expected oscillatory insulin secretion in the first degree relatives of type 2 diabetics is believed to be an early diagnostics in the progression of type 2 diabetes. 6 This peak at 13 to 14 min mark could be caused by the time lag from the insulin secretion to when the insulin is transported to interstitial space where insulin helps cells to uptake glucose. Furthermore, reduced glucose effectiveness is also an early change in T2DM and has been noted to be reduced in nondiabetic relatives of individuals with T2DM. 7 A key methodological aspect of evaluating insulin resistance and insulin secretion is the development of methods to accurately measure these parameters reliably in a wide variety of physiological situations. The Frequently Sampled Intravenous glucose Tolerance test (fsIVGTT) has been widely used as tool to measure insulin sensitivity (IS), insulin secretion, and glucose effectiveness (GE). 8 In fsIVGTT, after an overnight fasting, the subject is given a bolus of glucose (300 g/kg) through intravenous, followed by sampling plasma glucose and serum insulin at time marks 2 0 , 4 0 The insulin sensitivity index (S i ) is closely related to the IS determined by the hyperinsulinemic euglycemic glucose clamp test. 11 A commercial software, Penn Millennium MINMOD, 12 was developed based on MM. 13, 14 However, it has been noticed that MM overestimates glucose effectiveness. 15, 16 The MM is a three dimensional ordinary differential equation (ODE) system including glucose concentration in plasma and insulin concentration in interstitial space as state variables, while insulin concentration in plasma as an input to the interstitial space. The split of the two compartments can be thought of implicitly simulating the time delay of insulin secretion stimulated by the elevated glucose level. Since then, many IVGTT and related models have been proposed in the forms of delay differential equation (DDE) systems in a single compartment incorporating the time delay explicitly. [17] [18] [19] [20] [21] [22] De Gaetano and Arino 18 in 2000 introduced the following aggregated DDE model with a distributed time delay over the past interval
GðsÞds À b 2 I; 22 in which general delays in both insulin action on tissue glucose uptake and in the glucose action on pancreatic insulin secretion are considered. On the other hand, De Gaetano and his colleagues claimed that a simplified single discrete time delay model 24 is good enough to test the insulin sensitivity, and they discussed further the advantage of the simplified model. 25 In 2012, Li et al. 26 discussed the range of time delay and provided easy-to-check conditions for the globally asymptotic stability of the equilibrium point for the IVGTT model with a discrete time delay through Liapunov function approach.
Time delay of insulin secretion stimulated by increasing glucose may well be distributed in a past time sub-interval ½t À s 2 ; t À s 1 , instead of concentrated at a single time of the past (a discrete delay), or evenly distributed in a whole past interval ½t À s; t. In this paper, we introduce a novel and generic approach to modeling such delayed effect as follows:
with initial conditions GðtÞ ¼ /ðtÞ; t 2 ½Às À ; 0, where b; S g ; S i ; r, and d i > 0 are parameters for the hepatic glucose production, glucose effectiveness, insulin sensitivity, maximal rate of insulin secretion stimulated by glucose and the insulin degradation rate, respectively. Two parameters s > 0 and 0 < s together represent the time delay of insulin secretion as below
is a sigmoidal function with n ! 2 and the half saturation value a > 0. f(x) depicts the phenomenon that when insulin secretion is low when glucose level is low, but increases quickly when glucose level is elevated to some threshold level. 27 The time delay in (1.4) is distributed in the interval ½Às À ; Às þ . In other words, the secretion rate of insulin at current time t > 0 is related to the glucose level in the past sub-interval ½t À s À ; t À s þ . For the sake of convenience, we call average time delay s the center of delay and the radius of the delay interval.
It is easy to see that LðG t Þ ¼ 
where GðtÞ ¼ /ðtÞ; t 2 ½Às; 0. According to Lebesgue's Dominated Convergence Theorem, we can show that the solution ðG ðtÞ; I ðtÞÞ of (1.3) tends to the solution ðGðtÞ; IðtÞÞ of (1.6) as ! 0. The initial conditions of Model (1.3) are
while Ið0Þ ¼ I b . Here, G b and I b are the basal levels of the blood glucose and insulin concentration levels, t ¼ 0 is the ending time of the bolus glucose infusion, and 0 < d < s is the total time needed for the bolus glucose infusion and the time for glucose and insulin to increase from basal levels to the first peak levels. Usually, it takes 2 min for glucose infusion. We organize this paper as follows. In Sec. II, the positivity and uniform boundedness of the solutions of the model is established. In fact, we also show solutions are eventually uniformly bounded away from zero. In Sec. III, we provide some sufficient conditions that ensure the unique positive equilibrium is asymptotically or globally asymptotically stable. In Sec. IV, we investigate the existence of the Hopf bifurcation when s or varies and when both vary. In Sec. V, we fit our model with clinical data sets and demonstrate some of the interesting phenomena revealed by the new model. A brief discussion on the implications of our results are presented in the last section.
II. PRELIMINARIES
In this section, we present some basic results, such as the positive invariance of system (1.3), the existence of equilibrium, the boundedness of solutions and the persistence of the system. Proposition 2.1. The solutions ðGðtÞ; IðtÞÞ of system (1.3) are positive and bounded.
Proof. Let ðGðtÞ; IðtÞÞ be a solution of System (1.3). If there exists a t 0 > 0 such that
This shows that G(t) > 0 for all t in the interval of its existence. Similarly, if there exists a t 0 > 0 such that Ið t 0 Þ ¼ 0 but I(t) > 0 for t 2 ½0; t 0 , then from the second equation of (1.3), I 0 ð t 0 Þ ¼ rf ðLðGð t 0 ÞÞÞ Àd 2 Ið t 0 Þ ¼ rf ðLðGð t 0 ÞÞ. Since G t 0 ðhÞ ¼ Gð t 0 þ hÞ > 0 for h 2 ½Às À ; 0, then f ðLðGð t 0 ÞÞÞ > 0 by the definition of the function f. Thus, I 0 ð t 0 Þ > 0, which shows that I(t) > 0 for all t in the interval of its existence. As for the boundedness of G(t), by the first equation of (1.3)
Thus, G(t) is bounded by G M :¼ maxf/ðtÞ; b=S g g. Then, by the second equation of (1.3) we can obtain
Thus, I(t) is bounded by I M :¼ maxfIð0Þ; rf ðG M Þ=d i g. The boundedness statement implies that the solution exists for all t > 0. ٗ Proposition 2.2. System (1.3) is persistent, that is, solutions of (1.3) are ultimately bounded from above and from below by a positive lower bound.
Proof. From the proof of Proposition 2.1, we know that
and
Thus, we only need to find the solutions' positive bound from below.
From the first equation of (1.3) and (2.2), we have
Therefore,
which implies that
Then, from the second equation of (1.3), we can derive that
Hence
Then, for some g > 0
From above, we conclude that the solutions of (1.3) are eventually bounded from above and away from zero. ٗ
III. STABILITY OF THE EQUILIBRIUM
In this section, we will discuss the local and global stability of the positive equilibrium ðG Ã ; I Ã Þ of system (1.3), respectively.
Consider the algebraic equations defining any equilibrium point ðG
Then, Fð0Þ ¼ b > 0 and
FðGÞ¼ lim
Thus, FðÁÞ is a decreasing function for the arguments and it may hence have a unique positive root ðG Ã ; I Ã Þ. That is, the Model (1.3) has a unique equilibrium point ðG Ã ; I Ã Þ. In IVGTT, the blood glucose and insulin concentration levels return to their basal level after about three hours. So, we assume that
and therefore, the number of parameters of the Model (1.3) is reduced to 7.
Applying the same method of Theorem 3.1 in Ref. 23 , the following straight forward result is proved, which is consistent with the conclusion ðA 4 Þ for the discrete delay model in Ref. 26 on the global stability of the positive steady state.
Theorem 3.1. If n 1, then the unique equilibrium point ðG Ã ; I Ã Þ of (1.3) is globally asymptotically stable. The above result on stability does not depend on the value of the delay. In clinical test, the insulin release is abrupt stimulated by the bolus glucose infusion into intravenous, which implies that n > 1 to model the abrupt insulin release. We now turn to consider the case for n > 1.
Consider the model (
The unique equilibrium point ðG Ã ; I Ã Þ is mapped to (0, 0) for (3.2). The linearized system of (3.2) about its equilibrium point is given by
and the corresponding characteristic equation of (3.3) is
that is,
Clearly a 2 À 2c > 0, which is applied in Sec. IV A, and we can rewrite (3.4) as
When there is no delay, that is s ¼ 0 and ¼ 0, the characteristic equation becomes
and the real parts of the eigenvalues are negative, which implies that the trivial solution is globally asymptotically stable.
If the trivial solution of (3.3) is unstable for some s > 0 and > 0, there must exist x > 0 such that k ¼ ix is a solution of (3.6), i.e.,
Thus, we have
then the positive equilibrium ðG Ã ; I Ã Þ of (1.3) is locally asymptotically stable.
Remark 3.4. From Theorem 3.1 and Theorem 3.3, we find that when the parameters in the Model (1.3) are fixed, the shape of the function f ðxÞ ¼ x n a n þx n will affect the stability of the Model (1.3). If n 1, f is in the shape of the Michaelis-Menten kinetics. From Theorem 3.1, the model is globally asymptotically stable independent of the time delay. If n > 1, f(x) is in the sigmoidal shape. Notice that the inflection point of f is at G r ¼ ð nÀ1 nþ1 Þ 1 n a < a as n > 1. The slope of f attains its maximal value at G r . Theorem 3.3 provides a bound s b for the delay center s which depends on the slope of f at the plasma glucose basal level. So if G b < a, then smaller a causes the bound s b smaller. When G b is near to a, larger n will cause larger f 0 ðG b Þ and therefore smaller s b . Thus, the two parameters n and a together along with large s could destabilize the system (1.3). On the other hand, in the clinical setup of IVGTT, both glucose and insulin levels will return to their basal levels in about 3 h. This suggests that Model (1.3) may not be destabilized with reasonable parameter values. In Sec. IV, we will study when the system becomes unstable.
IV. BIFURCATION ANALYSIS
In this section, we seek Hopf bifurcations with respect to the parameters s and , respectively. We will show that for s varying from small to large, the system (1.3) could become unstable, and however, for varying from small to large, the system (1.3) could change from unstable to stable.
A. Hopf bifurcation with parameter s
We first show that a local Hopf bifurcation takes place when the delay center s varies.
Notice that (3.6) can be rewritten as
If as s increases, the trivial solution becomes unstable, then there must be a s Ã > 0 such that when s ¼ s Ã , FðixÞ ¼ 0 for some x > 0. And thus
Equivalently, and
ax :
From (4.4), it is easy to find that
If c < h, then gð0 þ Þ < 0. Therefore, there exists at least one rootx 2 0; p À Á such that gðxÞ ¼ 0. Notice that a 2 À 2c > 0 and sin x À x cos x > 0 for 0 < x < p. Thus
So we obtain the following lemma. 3) undergoes a Hopf bifurcation related not only to the value of s, but also to the value of . We shall demonstrate numerical investigation in Sec. V.
Next, we shall compare the delay lengths of the Hopf bifurcation in the three different cases: discrete delay, distributed delay in the past whole interval, and the distributed delay in the past sub-interval. In fact, the three type delay models can be considered in the following three cases: (A) ! 0, (B) ¼ s, and (C) 0 < < s.
In case (C), letŝ andx satisfy (4.6). Now, we compare the bifurcation valueŝ with the bifurcation values in other two cases.
Case (A). For ! 0 þ , the characteristic equation of (3.3) becomes
If ix 1 is the root of (4.7), similar to the above approach, we can obtain the following equation corresponding to the first equation of (4.3):
Then, we can find that if c < h, Eq. (4.8) has a positive root
In this case, s ¼ s 1 ¼ .3) and (4.8), we can easily get x 1 >x. That is, for the system (1.3), the bifurcation value in the case of the discrete time delay is smaller than that in the case of the distributed time delay. In other words, when the delay parameter s increases, the system with discrete time delay is sooner to be destabilized.
Case (B). For ¼ s, the first equation of (4.3) can be rewritten as
If a positive root x 2 of (4.9) exists under some conditions, then model (1.3) may undergo a bifurcation at
. In the case (C), < s, so we can compare the value of the right hand side of the first equation (4.3) with the right hand side of (4.9). Since sin ðxÞ x > sin ðsxÞ sx for 0 < < s < p=x, we know that the root of (4.9) x 2 <x. This possibly implies that the time delay distributed in a past sub-interval is more likely to destabilize a system than the time delay distributed in the whole past interval.
B. Hopf bifurcation with parameter
In Sec. IV A, we have proved that the system can undergo a Hopf bifurcation when s > 0 increases. In this subsection, we investigate the Hopf bifurcation of the system (1.3) when > 0 varies.
From Sec. IV A, we know that if c < h, then the strictly increasing function gðxÞ in (4.4) has a unique zerox with 0 <x <
which is equivalent to Therefore,
So, the relation between s and determined by (4.3) is monotonic. Notice also x ! 0 þ as s ! 1 and x ! 1 as s ! 0 þ . Now, let s Ã !ŝ be fixed. Then, there exists a unique Ã corresponding to s Ã that satisfies (4.3). We will show that Hopf bifurcation occurs at Ã when > Ã decreases in the following theorem whose proof is given in Appendix B.
Theorem 4.4. Given fixed s Ã >ŝ, let Ã be determined by (4.3). Assume that (4.10) holds. Then, when > Ã decreases, the system (1.3) undergoes a Hopf bifurcation at Ã > 0, namely, the unique equilibrium point ðG Ã ; I Ã Þ losses 2017) its stability and the system has a periodic solution, where s Ã and Ã satisfy (4.3).
C. Codimension-two bifurcation with parameters s and
In Secs. IV A and IV B, we have shown the existence of Hopf bifurcation when the delay center s increases or, for large s, when the delay interval radius decreases from large values. We now let both parameters s and vary simultaneously and investigate the codimension-two bifurcation.
From (4.11), we see that s is a decreasing function of x, while (4.12) implies that x is a decreasing function of . Therefore, by (4.13), the Hopf bifurcation value of s increases when the Hopf bifurcation value increases, which ensures the existence of a monotonic curve L formed by Hopf bifurcation points in the (s; )-plane.
We take the data of subject no. 13 as an example for simulation. Our intensive simulations confirm the existence of the smooth curve L dividing the (s; )-plane into two regions D s , in which the equilibrium point is stable, and D u , in which a limit cycle exists. As expected by the analytical result given by (4.13), no degeneracy is found in our numerical investigations. Furthermore, (4.13) shows that L is a monotonic curve. For clarity, we plot the curve L only in the window ½180; 280 Â ½10; 180 in the (s; )-plane in Fig. 1 . Remark 4.5. As aforementioned, under the clinical setup of IVGTT, the glucose and insulin concentrations will return to their basal levels, respectively. So, the steady state (at the basal levels) of the models that model the IVGTT should be stable with reasonable parameter values in physiological range. Figure 1 
V. SIMULATIONS
We have performed extensive numerical simulations using experimental data listed in Tables I and II Table III . We noticed that the profiles obtained by Model (1.3) fit the data better in the following aspects.
(a) From Figs. 2 and 3 , we observe that after a rapid insulin secretion, the insulin level may decline dramatically and rebound slightly; (b) From Table III , we see that the glucose effectiveness index S g is smaller than that estimated by Penn Millennium MINMOD, 12 which improves the known issue that MM overestimates the glucose effectiveness; 15, 16 and (c) From Table III , we see that the values of S g in all simulations are in a realistic range, which may not be true for the results presented in Refs. 24 and 26.
We estimate the model parameters in a hybrid fashion. We initially determine the parameter values by the Least Square Method (LSM) and then empirically fine-tuned the values to fit the data. This allows us to search for better fittings that match well with the initial rapid insulin secretion, subsequent decline in insulin levels and the second peak We have analytically shown the existence of Hopf bifurcation when the delay parameter s increases from small, and decreases from large, respectively. Taking the subject no. 13 as an example, we demonstrated the bifurcation in Fig. 4 when s increases, and in Fig. 5 when decreases, respectively, while all other parameter values are fixed. Figure 4 indicates that a Hopf bifurcation takes place at s 0 % 211, while Fig. 5 indicates that a Hopf bifurcation takes place when 0 % 110. Apparently, in such cases, the delay parameter values are out of physiological meaningful range. That is to say, with physiological meaningful parameter values, Model (1.3) predicts that the equilibrium is stable.
VI. DISCUSSION
It is known that MM overestimates the glucose effectiveness index S g . 15, 16 The estimated values of S g by our model (1.3) are more reasonable than those obtained by MM and the models in Refs. 24 and 26.This is achieved through better model fitting to the data set by adjusting the two parameters s and , which together describe the insulin secretion time delay interval.
Often, larger time delay in a delay differential equation system destabilizes the system through a Hopf bifurcation. The delayed effect of insulin secretion in response to the rapidly elevated glucose level is normally ranged in a few minutes to less than half of an hour. Our numerical simulations show that the Model (1.3) remains asymptotically stable for the delay value in physiological range. The Hopf bifurcation does not occur if the delay center is smaller than two hours. This indicates that in a typical clinical setting, the destabilization will not be a concern and the dynamics of glucose and insulin will approach their basal levels within three hours.
In this paper, we propose a novel approach to model the delayed effect in the past sub-interval centered at t À s with radius . Such approach is also applicable to other disciplines. Our analytical analysis and numerical study show that the delay center plays the major role and the delay radius takes the secondary role. We summarize our main mathematical findings as follows:
(A) when the delay center is fixed, the smaller the radius of the distribution interval of the delay, the more likely the system could be destabilized; (B) for a certain and finite time horizon, when the radius of the delay interval is fixed, the farther away of the delay center from the current time, the more likely the system could be destabilized.
We point out that the delay over the past sub-interval can be realized by selecting the kernel xðhÞ ¼ Minimal Model (MM) received its name since it has only three parameters, the minimal number of parameters in all well known IVGTT models. Model (1.3) has six parameters (notice that the parameter b is solvable by assuming its equilibrium point at the basal levels of glucose and insulin concentrations, respectively). If one model, say model 1, contains all the parameters of another model, say model 2, and the model 1 becomes model 2 when parameters not used in model 2 are set to be zero, then one can expect that model 1 shall fit data at least as good as model 2. Otherwise, more parameters in a model may not ensure better data fitting. In
Everett et al. 28 and in Rutter et al., 29 the authors reported that simpler ad hoc models actually fit data slightly better than their more complex models. However, Everett et al. 28 found that their more complex and realistic models do provide better predictions.
